MedPath

A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss

Not Applicable
Completed
Conditions
Obesity
Diabetes Mellitus
Interventions
Behavioral: Low carbohydrate ketogenic diet
Behavioral: Low-fat diet
Registration Number
NCT00108524
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

This study compares two types of diet interventions: a low carbohydrate ketogenic diet (Atkins) and a low-fat diet combined with a medication (Orlistat).

Detailed Description

Overweight and obesity are increasingly prevalent in the veteran population as well as the general public. For patients with obesity-associated illnesses, there are few effective treatment options available after failed attempts at diet and exercise, even though weight loss has been shown to alleviate these conditions. The purpose of this study is to compare the tolerability, safety, and efficacy of a low-carbohydrate ketogenic diet (Atkins) with a combination of a low-fat diet and Orlistat. The outcomes examined over a 48 week duration will include body weight, risk factors for heart disease (e.g., lipid profiles), and blood sugar. This is a randomized, parallel-intervention trial. Subjects (n=150) will be recruited from the Durham VAMC Ambulatory Care Clinics. All patients receive one of the two intensive weight loss interventions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
146
Inclusion Criteria
  • Participants must have a VA medical center primary care provider;
  • Failed first line diet and exercise recommendations;
  • In stable health by screening physical and lab tests;
  • Agrees to make regular visits per study protocol;
  • Has access to telephone;
  • Body mass index (BMI) > or = 27 with obesity-related illness OR BMI > or = 30 with no risk factors;
  • No contraindications to Orlistat;
  • Not pregnant or breast-feeding;
  • No serious mental health illness such as dementia or schizophrenia;
  • No use of a weight loss therapy in the month prior to screening.
Exclusion Criteria
  • No VAMC primary care provider
  • Unable to attend regular study visits
  • No access to telephone
  • BMI < 27
  • Contraindications to Orlistat
  • Pregnancy, breast feeding or planning to become pregnant
  • Unstable mental health illness
  • Use of a weight loss therapy in the month prior to screening

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low-Fat Diet plus OrlistatLow-fat dietParticipants receive counseling on a low fat diet over 48 weeks aimed at reducing fat and calorie intake, and additionally receive Orlistat taken 3 times daily.
Low Carbohydrate Ketogenic DietLow carbohydrate ketogenic dietParticipants receive dietary counseling over 48 weeks aimed at helping them to lower starch and sugar intake.
Low-Fat Diet plus OrlistatOrlistatParticipants receive counseling on a low fat diet over 48 weeks aimed at reducing fat and calorie intake, and additionally receive Orlistat taken 3 times daily.
Primary Outcome Measures
NameTimeMethod
Change From Baseline in Body Weight at 48 Weeksbaseline and 48 weeks

Body weight was measured using the same calibrated scale (Tanita Corp, Arlington Heights, Illinois) at each visit at the same time of day, with the participant wearing light clothing and no shoes.

Secondary Outcome Measures
NameTimeMethod
Change From Baseline in Risk Factors for Heart Disease (e.g., Lipid Profiles) at 48 Weeksbaseline and 48 weeks

Measured change in low-density lipoprotein cholesterol, or LDL-C, from baseline to 48 weeks.

Change From Baseline in Blood Sugar at 48 WeeksBaseline and 48 weeks

Measured change in Fasting glucose, mg/dL, from baseline to 48 weeks.

Trial Locations

Locations (1)

Durham VA Medical Center HSR&D COE

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath